quartzfiber4
About
Olaparib and also Pembrolizumab Strategy for BRCA1-Mutated along with PD-L1-Positive Intrahepatic Cholangiocarcinoma Recurrence and Metastasis: A Case Document.
Olaparib and also Pembrolizumab Strategy for BRCA1-Mutated along with PD-L1-Positive Intrahepatic Cholangiocarcinoma Recurrence and Metastasis: A Case Document.